Drug Index


Synonyms :

Sulphamethoxazole, TMP-SMX, Trimethoprim, Trimethoprim + Sulphamethoxazole

Mechanism :

Co-trimoxazole, (i.e. trimethoprim and sulfamethoxazole) is a synthetic antibacterial combination product.
Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA). Trimethoprim blocks the production of tetrahydrofolic acid from dihydrofolic acid by binding to and reversibly inhibiting the required enzyme, dihydrofolate reductase. Thus, co-trimoxazole blocks two consecutive steps in the biosynthesis of nucleic acids and proteins essential to many bacteria.

Indication :

  • Pneumocystis carinii pneumonia
  • Toxoplasmosis
  • Nocardiosis
  • Urinary tract infection
  • Skin and soft tissue infections
  • Bacillary dysentery
  • Otitis media

Contraindications :

Co-trimoxazole is contraindicated in patients with a known hypersensitivity to trimethoprim or sulfonamides and in patients with documented megaloblastic anemia due to folate deficiency. It is also contraindicated in pregnant patients at term and in nursing mothers, because sulfonamides pass the placenta and are excreted in the milk and may cause kernicterus and in pediatric patients less than 2 months of age.

Dosing :

<2 months: Contraindicated.

Mild to Moderate Infections:

>2 months: 8-10 mg TMP/kg/day in 2 divided doses.

>2 months: 15-20 mg TMP/kg/day PO in 4 divided doses. Max: 320 mg/day trimethoprim and 1.6 g/day of sulfamethoxazole.

Give for 5 days in shigellosis, 3 days for cholera and 21 days for PCP.

Prophylaxis: 150 mg TMP/m²/day PO in 2 divided doses hr for 3 days/week on consecutive or alternate days or 2 mg TMP/kg/dose PO every day, or 5 mgTMP/kg/dose two times weekly.

Adverse Effect :

Anorexia, nausea, vomiting, rash, urticaria, hypersensitivity reaction, Stevens-Johnson syndrome, Toxic epidermal necrolysis, agranulocytosis, aplastic anemia, hyponatremia, QT prolongation resulting in ventricular tachycardia and torsade de pointes.

Interaction :

Warfarin: Potentiates the anticoagulant activity of warfarin.
Phenytoin: Prolongs the half-life .
Methotrexate: A folate supplement should be considered.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
30-50Dose as in normal renal function
15-3050% of dose; PCP: 60 mg/kg twice daily for 3 days then 30 mg/kg twice daily
<1550% of dose; PCP: 30 mg/kg twice daily. (This should only be given if haemodialysis facilities are available)

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in GFR<15 mL/min
HDDialysed. Dose as in GFR<15 mL/ min
HDF/High fluxDialysed. Dose as in GFR<15 mL/ min
CAV/VVHDDialysed. Dose as in GFR=15– 30 mL/min

Hepatic Dose :

It is metabolized by the liver. Dosage adjustments may be necessary in patients with hepatic impairment.
03/21/2024 00:12:37 Cotrimoxazole
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0